This exciting European research initiative takes advantage of recent technical developments in translational medicine, to drive drug discovery and improve direct disease management in atopic eczema and psoriasis.

The project offers hugely exciting opportunities to better understand the causes of eczema and disease progression, opening the way for personalised medicine. Nationa Eczema Society is proud to be a member of the patient group board for this initiative.

For more information visit the project website.